MVP: Search for an Affordable Meningitis Vaccine in Africa

Authors: Thompson, Lindsay; Bishai, David M.; Steele, Michael E.; Champion, Claire
Product Type: Cases
Source: Johns Hopkins
Publication Year: 2011

[This document has not yet been rated] 359 views

The Meningitis Vaccine Project (MVP) case exemplifies how product development partnerships have reinvigorated research on vaccines for neglected diseases by distributing the multiple tasks of product development across a network of partners best suited for each task. The MVP vaccine in this case, MenAfriVac, was specifically targeted for use in low-income countries in Africa and designed to be made available to governments at a price of fifty cents per dose to protect against bacterial meningitis, an inflammation of brain tissues that causes an estimated 10,000 deaths among African children and young people each year.

Click here for more